Sharp, A., Bono, J. S. D., Cackowski, F. C., Mellado, B., Villarrubia, J. E., Ramirez, S. P., Lorente-Estelles, D., Loriot, Y., Mahammedi, H., Gravis, G., Pacey, S., Crabb, S. J., Brower, G., Nessly, M., Mutka, S., Cacovean, A., Gorbatchevsky, I., Fizazi, K. (2026). A phase 1/2, open-label, randomized, dose-finding and dose expansion study of gedatolisib in combination with darolutamide in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps304